Abstract
PIK3CA, which codes for the p110α catalytic subunit of phosphatidylinositol 3' kinase, is one of the most frequently mutated genes in human breast cancer. Here we describe a mouse model for PIK3CA-induced breast cancer using the ROSA26 (R26) knock-in system, where targeted Pik3ca alleles can be activated through transgenic expression of Cre recombinase. We mated shows cooperation with p53, which altered the specific tumors that formed. Thus, the two most frequently mutated genes in human breast cancer show cooperation in mammary tumor formation.
Introduction
The PI3K signaling pathway is one of the most frequently mutated pathways in cancer.
One common and direct mechanism by which the PI3K pathway is activated in breast, endometrial, colorectal, urinary tract, thyroid and ovarian cancer is through gain-of-function mutations in PIK3CA (1) (2) (3) . PIK3CA mutations are particularly important in human breast cancer, with activated alleles detected in 25-30% of tumors (4) (5) (6) (7) . These mutations have been found in ductal carcinoma in situ, suggesting that they play a role in breast tumor initiation (8) (9) (10) . In addition, they are present at high frequency in estrogen receptor α (ERα) positive, Her2/Neu + and triple negative breast tumors, suggesting an important role for mutant PIK3CA in etiology of multiple breast tumor subtypes (4) . Metaplastic breast cancers have the highest percentage of PIK3CA mutations (11) . Importantly, PIK3CA mutations can induce p53-dependent growth inhibition (12) and mutations in both genes occur together in some human breast tumors (13, 14) .
PIK3CA point mutations occur most often within two hotspots: the helix and kinase domains (1) . H1047R mutations in the kinase domain account for approximately 40% of breast cancer PIK3CA mutant alleles (4) . This mutant shows elevated kinase activity (15) (16) (17) and is capable of transforming cells in culture (18) , including mammary epithelial cells (19, 20) .
Despite the high frequency, and hence importance of this allele in breast cancer, there is no animal model to test for its role in transformation of mammary epithelium. Here we describe generation of a Cre-mediated system to conditionally express Pik3ca alleles in mouse tissues, and use of this system to test for induction of mammary tumor formation by Pik3ca deletion was confirmed using FP 5'-CACAAAAACAGGTTAAACCCAG-3', RP 5'-GAAGACAGAAAAGGGGAGGG-3' to amplify a 612bp fragment (24) . 
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Results
Generation of a Cre-inducible Pik3ca mammary tumor model
To test for the ability of Pik3ca Table 1 )(note, males were not studied). Some animals died abruptly, whereas most were sacrificed at humane endpoint due to lethargy and impaired breathing or solid tumor growth.
Decreased survival was not due to Pik3ca overexpression as R26- Table 1 , p < 1x10 -6 ). This was due to development of hamartomas in some R26-Pik3ca H1047R animals (data not shown), potentially through spontaneous activation of Pik3ca H1047R expression in endothelial cells (28) .
Pik3ca and p53 mutations cooperate in vivo
To test for cooperation between Pik3ca and p53, we mated R26-Pik3ca To quantify cell proliferation and apoptosis in each tumor type, we performed Ki67 immunohistochemistry and TUNEL analysis respectively (Table 1, Supplemental Table 3 
Discussion
PIK3CA is commonly mutated in human breast cancer. The PIK3CA locus is also amplified in some breast cancers (6, 40, 41) . To test for initiation of mammary tumor formation by PIK3CA alleles we generated syngeneic R26-Pik3ca We tested for PI3K pathway activation in major mammary tumor types that developed in our PIK3CA H1047R model mice. To this end we analyzed Akt phosphorylation, which was elevated in each tumor type. The modest level of Akt activation noted was somewhat surprising, although this was related to the use of whole mammary gland control tissue rather than linmammary epithelium for normalization (Supplemental Figure 5) . In any case, Akt-independent transformation has been noted in some breast tumors with a PIK3CA mutation (32) , and other PDK1 substrates are thought to play a role in this case. Indeed, transgenic mice expressing activated alleles of Akt1 from the MMTV LTR do not form mammary tumors, highlighting the importance of other PI3K pathways in breast cancer (44, 45) . Future studies will be required to define the importance of specific PIP3-responsive kinases and pathways in our Pik3ca 
